On January 14, 2026, the French Ministry of Health, Family, Autonomy and People with Disability published the Order setting DRG tariffs and tariffs for other packages and supplements for 2026. The released tariffs are in effect from January 1, 2026, and include new, higher DRG tariffs for several procedures, such as HIFU destruction of prostate lesions, as well as updates to packages for organ perfusion technologies for transplantation.

In January 2026, the Handbook on Health Councils was released in Denmark. The handbook explains the role, structure, responsibilities, and financing of the new Health Councils introduced as part of the ongoing Health Reform. A transitional structure of 17 preparatory Health Councils will be in place in 2026 to support the establishment of the permanent councils starting in 2027.

In January 2026, Italy entered the operational phase of the 2026–2028 National Health Technology Assessment Program for Medical Devices (PNHTA-DM) following the release of approximately €13 million from the national medical device governance fund. Coordinated by the National Agency for Regional Health Services (AGENAS), the program strengthens Italy’s national HTA system that will impact market access and procurement decisions for medical technologies.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of January 26th, we plan to work on 12 projects. Review the complete list of planned activities in this post.

On January 1, 2026, the specifications of the call for projects "Support for disruptive innovations in the implantable medical devices and surgical robotics sector" were approved. This initiative, part of the France 2030 investment plan, aims to support research and development projects targeting implantable medical devices and next-generation surgical robots.

On December 19, 2025, the Dutch Healthcare Authority (NZa) published the draft release of the 2027 DRG package (RZ27a). Seven new procedure codes, one new diagnosis code, and one new supplementary payment (OZP) are expected to be implemented across in-vitro diagnostics, obstetrics and gynecology, gastroenterology, urology, and other technology groups.

In December 2025, the HTA body of Tuscany Regional Healthcare published seven new rapid HTA reports on medical devices in cardiovascular, neurosurgery, neuromodulation, orthopedics, urology, and surgical fields.

In January 2026, the National Institute for Health and Disability Insurance (INAMI-RIZIV) updated “Low variability care” (APR-DRG) system for 2026. Overall, no significant changes were made to the system: no new DRGs were introduced, and tariffs remained nearly unchanged.

On December 31, 2025, the Ministry of Health, Family, Autonomy, and People with Disabilities published a Decree, amending the conditions of temporary coverage for innovative IVD tests via the RIHN framework (included in the List of Innovative Procedures Outside the Nomenclature, LAHN). Changes include extending the maximum duration of transitional coverage from five to nine years and lowering the annual tariff reductions from 20% to 10%. The LAHN 2026 was also released, reflecting the changes introduced by a Decree.

In 2026, the Dutch Healthcare Institute (ZIN) published the updated list of medical procedures reimbursed under basic health insurance with restrictions or limitations. The procedures have the so-called "claim" codes (aanspraakcodes). The Dutch Healthcare Authority assigns the "claim" codes based on positions published by the ZIN. The implemented changes included the introduction of two procedure codes for cryopreservation and storage of ovarian tissue.

On January 07, 2026, the submission period for Joint Scientific Consultations (JSCs) requests under the EU Health Technology Assessment Regulation (HTAR) framework opened. JSCs offer health technology developers the opportunity to seek scientific advice on the information and evidence required for a potential future Joint Clinical Assessment. Requests related to both medical devices and medicines can be submitted until February 04, 2026.

In January 2026, the Budget Law 2026 entered into force in Italy, introducing healthcare-related measures, including provisions for National Health Fund financing, increased budgets for recruiting healthcare personnel, initiatives supporting prevention, research, as well as investments in regional healthcare services and digitalization.